Literature DB >> 18569469

Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow.

E Anastasakis1, N Papantoniou, G Daskalakis, S Mesogitis, A Antsaklis.   

Abstract

Recent evidence suggests that the oxidative stress is an important factor in the pathophysiology of pre-eclampsia. The purpose of this study was to evaluate the possible relationship between increased resistance at the Doppler assessment of the uterine arteries between 20-23 gestational weeks and biochemical markers of oxidative stress, with the development of pre-eclampsia and/or growth restricted infants. This was a prospective study of 34 pregnant women with normal uteroplacental flow and 30 women with abnormal uterine arteries Doppler analysis (mean PI >or= 1.60) during the transvaginal assessment of the uterine arteries at the routine anomaly scan. Blood samples were obtained in order to assess the plasma oxidative stress, namely malondialdehyde (MDA) and uric acid levels. The MDA was significantly higher in the group of women with abnormal uterine arteries Dopplers. This group is at increased risk for the development of pre-eclampsia. The uric acid levels did not differ significantly between the two groups of women. There was no significant difference regarding the sensitivity or the specificity of the uterine arteries Doppler examination in detecting pre-eclampsia in comparison to the combination of oxidative stress and Doppler's. Our study provides additional evidence regarding the role of oxidative stress in the pathophysiology of pre-eclampsia. Whether antioxidant supplementation in the group of women with abnormal uterine Doppler's is effective in reducing the incidence of the disease remains to be established.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18569469     DOI: 10.1080/01443610802042852

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Biochemical tests of placental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age infants.

Authors:  Alexander Ep Heazell; Dexter Jl Hayes; Melissa Whitworth; Yemisi Takwoingi; Susan E Bayliss; Clare Davenport
Journal:  Cochrane Database Syst Rev       Date:  2019-05-14

2.  Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort study.

Authors:  Chadi Yazbeck; Olivier Thiebaugeorges; Thierry Moreau; Valérie Goua; Ginette Debotte; Josiane Sahuquillo; Anne Forhan; Bernard Foliguet; Guillaume Magnin; Rémy Slama; Marie-Aline Charles; Guy Huel
Journal:  Environ Health Perspect       Date:  2009-06-26       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.